Osmolex ER
My Prescription
Payment
Select pharmacy



$517.88
Print or send this coupon to your phone
About Osmolex ER
Drug Details
Osmolex ER, containing amantadine, is a medication prescribed for adults to manage Parkinson's disease and certain movement-related side effects known as extrapyramidal symptoms, which can be induced by other drugs. This medication is typically taken once daily in the morning. It functions as an NMDA antagonist, which is believed to increase dopamine levels by blocking NMDA receptors in the brain. This action helps alleviate movement symptoms like tremors, stiffness, and slowness. Patients should be aware of potential side effects, including nausea, dizziness, lightheadedness, and difficulty sleeping. It is crucial to follow medical advice and not switch brands without consulting a healthcare professional. Always discuss with your doctor or pharmacist before starting any new medication or treatment plan.
Price history for Osmolex ER
30 Tablet Extended Release 24 Hours, 129MG
Average retail price for Osmolex ER
Average SaveHealth price for Osmolex ER
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Osmolex ER dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 129MG | 30 Tablet Extended Release 24 Hours | $518.38 | $17.28 |
| 129MG | 90 Tablet Extended Release 24 Hours | $1,539.13 | $17.10 |
| 193MG | 30 Tablet Extended Release 24 Hours | $518.38 | $17.28 |
| 193MG | 90 Tablet Extended Release 24 Hours | $1,539.13 | $17.10 |
Osmolex ER FAQs
As of the latest available information, Osmolex ER has not been officially discontinued. However, availability can vary, and it is advisable to check with local pharmacies or healthcare providers for the most current information regarding its status.
Osmolex is used to treat Parkinson's disease and drug-induced extrapyramidal reactions. It helps to improve muscle control and reduce stiffness, allowing for more normal movements.
Gocovri and Osmolex ER are both extended-release formulations of amantadine, but they are approved for different uses and have different release profiles. Gocovri is specifically approved for the treatment of dyskinesia in patients with Parkinson's disease who are receiving levodopa-based therapy, with or without concomitant dopaminergic medications. It is designed to provide a higher concentration of amantadine in the morning and throughout the day. Osmolex ER, on the other hand, is approved for the treatment of Parkinson's disease and drug-induced extrapyramidal reactions in adult patients. It has a different release profile, providing a more consistent release of amantadine throughout the day.
Yes, Osmolex ER is FDA approved. It is used for the treatment of Parkinson's disease and drug-induced extrapyramidal reactions in adult patients.
Yes, Osmolex ER is available in the USA. It is a medication used for the treatment of Parkinson's disease and drug-induced extrapyramidal reactions.